Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection

Columbia University, New York

Weill Cornell Medical College, New York

Lehigh Valley Hospital, Allentown

Levine Cancer Institute-Atrium Health University City, Charlotte

Emory University, Atlanta

CHU Bordeaux, Bordeaux

Miami Cancer Institute at Baptist Health, Miami

Servicio de Medicina Interna, Hospital Universitario de Salamanca, Universidad de Salamanca, Salamanca

Norton Healthcare, Louisville

CHU Nantes, Nantes

Michigan Center of Medical Research, Royal Oak

Karmanos, Detroit

Michigan Center of Medical Research, Farmington Hills

Advocate Christ Medical Center, Oak Lawn

University of Kansas Medical Center, Kansas City

CHU Lyon, Lyon

Baylor Scott & White Dallas, Dallas

UCLA, Los Angeles

Kaiser Permanente San Francisco, San Francisco

Kaiser Permanente Oakland, Oakland

UC Davis Health, Sacramento

Kaiser Permanente Sacramento, Sacramento

MultiCare Institute for Research & Innovation (Puget Sound), Tacoma

Boston Medical Center, Boston

Hospital Hietzing, 2. Medical department - Center for Diagnosis and Therapy of Rheumatic Diseases, Vienna

Hadassah MC, Jerusalem

Hasharon Medical Center, Petah Tikva

Sheba Medical Center, Tel Litwinsky

Hospital Universitari Vall d'Hebron, Barcelona

Princess Royal University Hospital, Kent

Kings College Hospital, London

The Royal Marsden Hospital, London

University Hospitals Plymouth NHS Trust, Plymouth